Operon Technologies, Inc.

Operon, a wholly owned subsidiary of QIAGEN N.V., is a market-leading DNA synthesis company that manufactures and sells synthetic oligonucleotides, genes, and microarray products to industry and academic life-science researchers worldwide. With production facilities in the US and Europe, Operon has earned a reputation for unsurpassed quality and rapid service. Operon's products are used for a range of applications, including high-throughput genetic mapping, genome characterization, and other genetic research techniques that underlie modern drug discovery and functional genomics. Operon believes that its unique technologies and capabilities have contributed to its leading role in today's fast growing genomics markets.

Product Highlight

Operon Microarray Database

Operon is pleased to announce the release of the Operon Microarray Database (OMAD), which offers comprehensive information about our Human, Mouse, and Yeast Array-Ready Oligo Sets. The database provides specifics on each designed oligo and its representative gene or ORF. Additionally, the database features the oligo name, the gene name, its description, and links to public domain databases. The database also includes potential cross-hybridization (X-Hyb) information for each oligo, which may be used to provide a more in-depth analysis of the results of hybridization experiments.

Currently Available

Tuberculosis Genome Oligo Set
Yeast Genome Oligo Set
Human Genome Oligo Set
Mouse Genome Oligo Set
Malaria Genome Oligo Set

Coming Soon

Drosophila Genome Oligo Set
C.elegans Genome Oligo Set